Adenovirus-associated pneumonia in South African children: Presentation, clinical course and outcome

M Zampoli1, Z Mukuddem-Sablay

  • 1Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and Faculty of Health Sciences, University of Cape Town, South Africa. m.zampoli@uct.ac.za.

Insights

Adenovirus causes severe pneumonia and persistent lung disease (PLD) in children. Intensive care unit admission and positive blood cultures indicate a poor prognosis for pediatric adenovirus pneumonia.

Area of Science:

  • Pediatric infectious diseases
  • Respiratory medicine
  • Virology

Background:

  • Viruses are significant causes of childhood pneumonia.
  • Adenovirus is identified as a key etiological agent in pediatric respiratory infections.

Purpose of the Study:

  • To examine the clinical features, disease severity, and outcomes of children with adenovirus-associated pneumonia (AVP).
  • To identify risk factors associated with severe outcomes in pediatric AVP.

Main Methods:

  • Retrospective analysis of 206 AVP cases over 12 months.
  • Data collected included demographics, clinical course, and outcomes such as persistent lung disease (PLD) and mortality.
  • Statistical analysis identified risk factors for mortality and PLD.

Main Results:

  • Adenovirus-associated pneumonia (AVP) affected children with a median age of 12 months.
  • Malnutrition (34.0%) and HIV infection (6.8%) were noted comorbidities.
  • Persistent lung disease (PLD) developed in 14.1% of cases, often associated with hypoxia and ICU admission.
  • Mortality occurred in 8.7% of cases, with independent risk factors including ICU admission and positive blood cultures.

Conclusions:

  • Adenovirus is a significant cause of pneumonia and persistent lung disease (PLD) in young children, particularly in South Africa.
  • Intensive care unit (ICU) admission and positive blood cultures are indicators of poor outcomes in pediatric AVP.
Abstract

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.7K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
976
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K